|
Existing biological drug patents seem to be transparent to PLX.
PLX will actually obtain the R&D and NRE for these drugs almost for free. Upon approval (=most of the costs) PLX will easily compete with the existing companies because PLX's production cost will be ~10% of their production cost. Moreover, PLX's production has a builtin firewall against viruses and can be easily scaled up. Sentiment : Strong Buy Rating :
 (No ratings) |
61/Male |
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
Messages in Topic
| Subject | Author | Rating | Time of Post (ET) | ||
|---|---|---|---|---|---|
|
This company has a lot of potential in the short(buy ou...
|
heydarmotar... |
|
4-Nov-09 01:56 am | ||
|
AGREE!
|
avwyahav | Rate it | 4-Nov-09 05:50 am | ||
|
Re: I ain't selling
|
dfkerem | Not rated | 4-Nov-09 07:27 am |
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
0.13